Alerts
PDF
Other content recommended for you
- Access to investigational medicinal products for minors in Europe: ethical and regulatory issues in negotiating children's access to investigational medicines
- Fair, just and compassionate: A pilot for making allocation decisions for patients requesting experimental drugs outside of clinical trials
- Donor-funded research: permissible, not perfect
- Engaging African ancestry participants in SLE clinical trials
- Efficacy and safety of avelumab treatment in patients with metastatic Merkel cell carcinoma: experience from a global expanded access program
- Development of a home-visit nursing scale for helping spousal caregivers of terminal cancer patients develop positive perspectives of their caregiving experiences: a cross-sectional study
- Quackery or quality: the ethicolegal basis for a legislative framework for medical innovation
- Phase I oncology trials: why the therapeutic misconception will not go away
- Multidisciplinary molecular tumour board: a tool to improve clinical practice and selection accrual for clinical trials in patients with cancer
- FDA proposes changes in access and charges for experimental drugs